Belpointe Asset Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-17,873
Closed -$15.8K 3918
2022
Q4
$15.8K Buy
+17,873
New +$15.8K ﹤0.01% 2346
2021
Q4
Sell
-15,923
Closed -$121K 1271
2021
Q3
$121K Sell
15,923
-400
-2% -$3.04K 0.01% 1075
2021
Q2
$158K Buy
16,323
+2,300
+16% +$22.3K 0.01% 931
2021
Q1
$116K Buy
+14,023
New +$116K 0.01% 945